
Loading, please wait...

Loading, please wait...

Gastric malignancy remains a formidable global health challenge with substantial clinical morbidity and mortality. Among its adverse pathological hallmarks, gastric cancer perineural invasion serves as an independent marker of poor prognosis, systemic dissemination, and surgical recurrence. Historically, clinicians viewed nerve invasion as an incidental, passive path of least resistance through low-pressure perineural sheaths. However, contemporary molecular pathology demonstrates that active reciprocal signaling between malignant epithelium, peripheral nerve fibers, and the surrounding stroma governs this process. Emerging single-cell and spatial transcriptomic platforms now allow researchers to dissect this specialized perineural microenvironment with unprecedented cellular resolution.
Perineural invasion profoundly complicates the clinical management of gastric adenocarcinoma. When cancer cells penetrate the perineural space, patients experience higher rates of local recurrence following gastrectomy. Furthermore, these patients frequently suffer from reduced disease-free survival and diminished overall survival regardless of initial staging. Consequently, surgical oncologists and pathologists prioritize accurate identification of nerve invasion in resected specimens. Standard histopathology detects nerve infiltration, yet routine assessments fail to reveal the precise stromal phenotypes facilitating tumor migration along nerve sheaths. In clinical practice, perineural involvement frequently coincides with resistance to systemic chemotherapy and standard adjuvant regimens. Therefore, deciphering the dynamic biological architecture within the perineural niche represents an urgent imperative. By elucidating how specialized stromal cells support neurotropism, investigators can uncover actionable therapeutic targets. Ultimately, converting these molecular insights into clinical strategies may significantly improve survival outcomes for individuals presenting with locally advanced and invasive gastric neoplasms.
To unravel the microenvironmental heterogeneity governing invasive stomach tumors, investigators implemented an integrated multi-omics pipeline. Researchers harmonized bulk transcriptomic patient cohorts with high-resolution single-cell RNA sequencing and spatial transcriptomic profiling. In addition, the investigative team utilized phenotype projection, advanced computational deconvolution, pseudotime trajectory analysis, and regulon mapping. This sophisticated approach allowed researchers to dissect the complex cellular ecosystem without losing critical anatomical context. Most importantly, spatial transcriptomics preserved the native tissue architecture, illuminating precisely where specific stromal subpopulations reside relative to neural structures. Using multiplex immunofluorescence, the investigators validated their computational predictions directly within patient tumor samples. Consequently, they localized distinct cellular communities operating within the perineural niche. This rigorous multi-modal methodology bridges the gap between deep gene expression profiling and microscopic anatomical pathology. As a result, clinicians gain a comprehensive, spatially resolved map detailing the coordinated cellular behaviors that promote neural tropism in gastrointestinal oncology.
Through robust multi-modal profiling, the investigators discovered a 13-gene stromal signature strongly enriched in nerve-invasive gastric tumors. This signature, designated the stromal PNI-associated signature, correlated directly with advanced clinical stage and adverse patient outcomes. Furthermore, non-negative matrix factorization independently confirmed a convergent transcriptional program operating within these aggressive malignancies. Cross-modal analyses pinpointed this signature specifically to a distinct subset of cancer-associated fibroblasts expressing Secreted Frizzled-Related Protein 2 (SFRP2). These SFRP2+ cells display prominent myofibroblastic features and selectively occupy nerve-rich microenvironments. Multiplex immunofluorescence confirmed an intense enrichment of SFRP2+ and PDPN+ myofibroblastic cancer-associated fibroblasts immediately adjacent to TUBB3+ peripheral nerve fibers. Notably, normal stomach stroma and non-invasive tumor margins lacked this specialized cellular accumulation. Therefore, SFRP2+ myofibroblastic fibroblasts serve as direct cellular orchestrators of gastric cancer perineural invasion, remodeling local extracellular matrix barriers to facilitate directional tumor migration along nerve tracts.
Beyond identifying this fibroblast state, the researchers elucidated the distinct intracellular signaling circuitry driving its pro-invasive functions. Transcriptomic trajectory and regulon analysis revealed pronounced activation of the pre-B-cell leukemia transcription factor 1 (PBX1) regulon inside SFRP2+ fibroblasts. Concurrently, metabolic pathway mapping demonstrated enhanced retinoid metabolism tightly coupled to aldehyde dehydrogenase 1 family member A3 (ALDH1A3) expression. This coordinated signaling cascade appears to govern the functional specialization of these perineural fibroblasts. Retinoid metabolism produces bioactive metabolites that actively influence both stromal matrix stiffening and neurotrophic factor release. Meanwhile, the PBX1 regulon directs transcriptional programs that promote cell survival, matrix remodeling, and paracrine communication within hostile microenvironments. Consequently, the interplay between ALDH1A3-mediated metabolic shifts and PBX1 gene regulation equips SFRP2+ fibroblasts to establish a supportive physical and biochemical sanctuary for infiltrating tumor cells. Thus, this regulatory axis provides a mechanistic framework underlying stromal-neural crosstalk during gastrointestinal tumor invasion.
These breakthrough discoveries hold substantial translational relevance for modern gastroenterology, oncology, and surgical pathology. Currently, diagnostic pathology categorizes perineural invasion as a binary histopathologic finding without molecular subtyping. Incorporating the 13-gene stromal signature or detecting SFRP2+ PDPN+ fibroblasts via immunohistochemistry could significantly refine post-operative risk stratification. Furthermore, identifying high-risk patients facilitates tailored surveillance regimens and guides personalized adjuvant treatment selection. From a therapeutic standpoint, targeting standard cancer-associated fibroblasts has historically proven challenging due to their functional heterogeneity and tumor-suppressive subsets. However, selectively disrupting the SFRP2+ myofibroblastic niche offers a more precise therapeutic avenue. Specifically, targeting the ALDH1A3 retinoid pathway or inhibiting PBX1 transcriptional activity may dismantle the neuro-supportive niche without depleting protective stromal elements. In conclusion, combining conventional cytotoxic chemotherapy with targeted microenvironment-directed interventions could effectively prevent neural dissemination and improve long-term disease control in aggressive gastric cancer.
Perineural invasion describes the infiltration and tracking of neoplastic cells around or through peripheral nerve sheaths. In gastric adenocarcinoma, this process reflects advanced local aggressiveness and portends a higher risk of recurrence. Rather than passive physical spread, nerve invasion involves active chemical signaling between cancer cells, nerves, and specialized cancer-associated fibroblasts that remodel adjacent tissue architecture to foster directional tumor extension.
SFRP2+ myofibroblastic fibroblasts physically concentrate around peripheral nerves in invasive gastric tumors. These specialized cells express a 13-gene pro-invasive signature that correlates with disease progression and shortened patient survival. By localizing immediately adjacent to neural fibers, SFRP2+ fibroblasts actively remodel extracellular matrices and secrete signaling factors that facilitate neural infiltration, establishing them as valuable prognostic biomarkers and attractive therapeutic targets.
ALDH1A3 drives critical steps in retinoid biosynthesis, generating active metabolites that regulate transcriptional programs involved in stromal remodeling and cellular survival. In SFRP2+ fibroblasts, elevated ALDH1A3 activity functions alongside the PBX1 transcription factor regulon to maintain a pro-invasive stromal phenotype. Consequently, this metabolic pathway supports stromal-neural interactions, making ALDH1A3-linked signaling a viable candidate for pharmacological disruption to prevent tumor cell neurotropism.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A landmark study integrating single-cell and spatial transcriptomics identifies an SFRP2+ myofibroblastic CAF state that drives gastric cancer perineural invasion through ALDH1A3-linked retinoid metabolism and PBX1 regulon activation, offering new therapeutic opportunities for aggressive stomach cancer.
Today

A cross-validation study in early-stage lung cancer evaluated algorithms mapping FACT-L to EQ-5D-5L utilities. Ridge regression achieved the lowest error, outperforming complex machine learning models such as random forest, neural networks, and XGBoost, underscoring the enduring value of regularized linear models.
Today

A meta-analysis of 9 randomized controlled trials evaluated health-related quality of life when adding PD-1/PD-L1 inhibitors to standard therapy for endometrial and cervical cancer. Adding immunotherapy did not detectably change global quality of life or worsen functional and symptom domains.
Today

A cross-sectional study evaluates the critical intersection between acute surgical pain, kinesiophobia, and fall risks during initial mobilization after cardiac surgery, emphasizing targeted nursing strategies.
Today

A comprehensive meta-analysis reveals a decline in hip avascular necrosis following kidney transplantation to 3.45% post-2010. This decline reflects modern steroid-sparing immunosuppression, while highlighting geographic variations and the importance of early diagnosis.
Today

Single-cell transcriptomics reveals that STAP2 promotes retinal endothelial dysfunction in diabetic retinopathy through CXCR4 signaling. In vivo and in vitro studies show STAP2 knockdown reduces capillary drop-out and vascular leakage, uncovering a novel therapeutic target beyond anti-VEGF therapies.
Today